STOCK TITAN

Heartflow (HTFL) CMO sells 9,219 shares after option exercise under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Heartflow, Inc. Chief Medical Officer Campbell Rogers reported an option exercise and related share sale in Common Stock. On May 18, 2026, he exercised stock options to acquire 9,219 shares at $19.00 per share, then sold 9,219 shares in an open-market transaction at $28.34 per share.

The filing shows he now holds 78,731 Common Stock shares directly. In addition, multiple trusts associated with him and his spouse report indirect holdings, including 50,754 shares by The Campbell Rogers Revocable Trust and 26,012 shares by a spouse’s trust. The footnotes state the option exercise and sale were carried out under a pre-arranged Rule 10b5-1 Trading Plan adopted on December 12, 2025.

Positive

  • None.

Negative

  • None.
Insider Rogers Campbell
Role Chief Medical Officer
Sold 9,219 shs ($261K)
Type Security Shares Price Value
Exercise Stock Options 9,219 $0.00 --
Exercise Common Stock 9,219 $19.00 $175K
Sale Common Stock 9,219 $28.34 $261K
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Stock Options — 101,410 shares (Direct, null); Common Stock — 87,950 shares (Direct, null); Common Stock — 22,615 shares (Indirect, By Campbell Rogers 2019 Irrevocable Trust)
Footnotes (1)
  1. The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025. The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.
Shares sold 9,219 shares Common Stock sold in open-market transaction on May 18, 2026
Sale price $28.34 per share Price for 9,219 Common Stock shares sold
Options exercised 9,219 options Stock options exercised into Common Stock on May 18, 2026
Exercise price $19.00 per share Exercise or conversion price of stock options
Direct shares after transaction 78,731 shares Common Stock directly held by Rogers following transactions
Revocable trust holdings 50,754 shares Common Stock held by The Campbell Rogers Revocable Trust
Spouse’s trust holdings 26,012 shares Common Stock held by spouse’s trust
Option expiration August 7, 2035 Expiration date for the reported stock options
Rule 10b5-1 Trading Plan regulatory
"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Options financial
""security_title": "Stock Options""
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
indirect ownership financial
""ownership_type": "indirect""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rogers Campbell

(Last)(First)(Middle)
C/O HEARTFLOW, INC.
135 MAIN STREET, SUITE 1000

(Street)
SAN FRANCISCO CALIFORNIA 94105

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Medical Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/18/2026M(1)9,219A$1987,950D
Common Stock05/18/2026S(1)9,219D$28.3478,731D
Common Stock22,615IBy Campbell Rogers 2019 Irrevocable Trust
Common Stock46,159IBy CR Asset Protection Trust of 2023
Common Stock26,012IBy Spouse's Trust
Common Stock50,754IBy The Campbell Rogers Revocable Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options$1905/18/2026M(1)9,219 (2)08/07/2035Common Stock9,219$0101,410D
Explanation of Responses:
1. The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
2. The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.
/s/ Nga Van, by power of attorney05/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Heartflow (HTFL) report for Campbell Rogers?

Heartflow’s Chief Medical Officer Campbell Rogers exercised stock options and sold shares. He exercised 9,219 options at $19.00 per share and sold 9,219 Common Stock shares at $28.34 per share, all recorded on May 18, 2026.

How many Heartflow (HTFL) shares did Campbell Rogers sell and at what price?

Campbell Rogers sold 9,219 Heartflow Common Stock shares at $28.34 per share. The transaction is classified as an open-market sale and occurred on May 18, 2026, immediately following an option exercise for the same number of shares.

What stock options did Campbell Rogers exercise in this Heartflow (HTFL) Form 4?

Rogers exercised 9,219 stock options for Heartflow Common Stock at an exercise price of $19.00 per share. These options relate to a grant that vests in monthly installments until August 7, 2029, conditioned on continued service with the company.

How many Heartflow (HTFL) shares does Campbell Rogers hold after the reported transactions?

After the reported transactions, Rogers directly holds 78,731 Heartflow Common Stock shares. The filing also lists additional indirect holdings through several trusts, including shares held by The Campbell Rogers Revocable Trust and a spouse’s trust.

Were Campbell Rogers’ Heartflow (HTFL) trades made under a Rule 10b5-1 plan?

Yes. A footnote explains the option exercise and subsequent sale were executed under a Rule 10b5-1 Trading Plan adopted by Rogers on December 12, 2025. Such plans pre-schedule trades, making their timing more routine and less discretionary.

What indirect Heartflow (HTFL) holdings are reported for Campbell Rogers?

The Form 4 lists several indirect Heartflow holdings. These include 50,754 Common Stock shares held by The Campbell Rogers Revocable Trust, 26,012 shares by a spouse’s trust, 46,159 shares by the CR Asset Protection Trust of 2023, and 22,615 shares by a 2019 irrevocable trust.